We propose that enhancing PINK1/Parkin-mediated mitophagy and the expression of SIRT1, PGC-1α, and TFAM in podocytes may be a novel strategy for the treatment of DKD. This evidence concerns the gene PPARGC1A and diabetic kidney disease.